ten23 health®, located in Basel and Visp, Switzerland, is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups: we develop, manufacture, and test modern medicines. We support our clients in developing differentiated, stable, usable, and safe injectable treatment options for patients.
ten23 health® combines the latest scientific findings with proven and tested world-class industry and regulatory expertise to forge new paths for supporting clients. We provide our innovative services in a fair and sustainable manner, respecting people’s health and the future of our planet. ten23 health® is a B Corp member and solidly financed through the long-term commitment of 3i Group, an internationally reputable equity partner.

Type of Drugs Manufactured:

Small Molecule;Biologics;Cell & Gene Therapy

CDMO Services:

Drug Substance Manufacturing (API);Drug Product Formulation (FDF);Research & Development;Packaging;Regulatory Services;Analytical Development

No. of Manufacturing Facilities:

2

Facilities Locations:

Europe

Regulatory Approvals for facilities:

FDA (United States);ISO;GMP

Manufacturing Technologies:

Cartridges;Liquids;Pre-Filled Syringes (PFS);Sterile Vials